Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.46
-0.01 (-0.18%)
At close: Mar 4, 2026, 4:00 PM EST
5.46
0.00 (0.03%)
After-hours: Mar 4, 2026, 7:36 PM EST
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $134.02 million as of March 4, 2026. Its market cap has increased by 24.27% in one year.
Market Cap
134.02M
Enterprise Value
22.74M
1-Year Change
24.27%
Ranking
Category
Stock Price
$5.46
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $134.02M, a decrease of -24.18%. That is a compound annual growth rate of -15.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 134.26M | 27.51% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 145.71M |
| Sangamo Therapeutics | 145.66M |
| Adagene | 139.98M |
| Immunic | 139.60M |
| Connect Biopharma Holdings | 138.64M |
| Oramed Pharmaceuticals | 134.53M |
| Polaryx Therapeutics | 132.56M |
| Black Diamond Therapeutics | 131.04M |